Acadian Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,009
Closed -$58K 2131
2024
Q3
$58K Buy
+4,009
New +$58K ﹤0.01% 1758
2022
Q2
Sell
-39,720
Closed -$139K 1845
2022
Q1
$139K Sell
39,720
-38,914
-49% -$136K ﹤0.01% 1290
2021
Q4
$522K Buy
+78,634
New +$522K ﹤0.01% 999